<!DOCTYPE html>
<html>
<head>
  <title>Katalin Karikó – Profile</title>
  <style>
    body { font-family: Arial, sans-serif; margin: 2rem auto; max-width: 960px; line-height: 1.5; }
    aside.infobox { float: right; width: 280px; margin: 0 0 1rem 1.5rem; border: 1px solid #ccc; padding: 0.5rem; font-size: 0.9rem; }
    aside.infobox h3 { text-align: center; margin-top: 0; }
    aside.infobox table { width: 100%; border-collapse: collapse; }
    aside.infobox td { padding: 0.25rem 0; vertical-align: top; }
    h1 { margin-top: 0; }
    footer.categories { font-size: 0.8rem; color: #555; border-top: 1px solid #ddd; padding-top: 0.5rem; margin-top: 2rem; }
  </style>
</head>
<body>
  <h1>Katalin Karikó</h1>
  <aside class="infobox">
    <h3>Katalin Karikó</h3>
    <table>
      <tr><td><strong>Full name</strong></td><td>Katalin Karikó</td></tr>
      <tr><td><strong>Born</strong></td><td>17 January 1955<br>Pécs, Hungary</td></tr>
      <tr><td><strong>Nationality</strong></td><td>Hungarian, American</td></tr>
      <tr><td><strong>Occupation</strong></td><td>Biochemist, biotechnology researcher</td></tr>
      <tr><td><strong>Years active</strong></td><td>1980s–present</td></tr>
      <tr><td><strong>Known for</strong></td><td>Development of mRNA technology, COVID-19 vaccines</td></tr>
      <tr><td><strong>Website</strong></td><td><a href="https://www.nih.gov/about-nih/what-we-do/nih-almanac/national-institute-child-health-human-development">NIH profile</a></td></tr>
    </table>
  </aside>
  <p>Katalin Karikó is a Hungarian-American biochemist known for pioneering foundational work in messenger RNA (mRNA) technology, which became a critical component for COVID-19 vaccines. Her research in the 1980s and 1990s focused on modifying RNA to reduce its immunogenicity, enabling its safe use in therapeutics. Her persistence and innovative approach eventually helped overcome major scientific challenges, leading to the development of mRNA-based vaccines that have saved millions of lives globally.</p>
  
  <h2>Early life and education</h2>
  <p>Born in Pécs, Hungary, Karikó developed an early interest in science and pursued her higher education in biochemistry at the University of Szeged, earning her doctorate in 1982. She faced academic and professional obstacles in Hungary due to her scientific views and political climate, prompting her to relocate to the United States in the late 1980s. Her dedication to research and her refusal to abandon her ideas about RNA modifications set the foundation for her groundbreaking work.</p>
  
  <h2>Career</h2>
  <p>Karikó began her research career at the University of Szeged before moving to the United States, where she joined multiple institutions. She worked at the University of Pennsylvania and later at BioNTech and Moderna, biotech companies at the forefront of mRNA technology development. Despite facing skepticism and funding challenges, her persistence led to key innovations in RNA stability and delivery, culminating in the core technology behind the Pfizer-BioNTech and Moderna COVID-19 vaccines. Her contributions have transformed vaccine science and opened new avenues for gene therapy and personalized medicine.</p>
  
  <h2>Notable works and projects</h2>
  <p>Her most notable contributions include the development of modified nucleosides in mRNA to reduce immune responses, enabling effective and safe delivery into human cells. Her research played a crucial role in the rapid development of mRNA COVID-19 vaccines during the pandemic. She co-founded several biotech startups to further advance mRNA applications in therapeutics beyond vaccines, including treatments for cancer and rare diseases.</p>
  
  <h2>Personal life</h2>
  <p>Karikó is known for her quiet determination and modest lifestyle. She is married with children and has spoken publicly about the importance of perseverance in scientific research. She balances her professional pursuits with a commitment to family and maintains a passion for mentoring young scientists. Her experiences as an immigrant and researcher underscore her resilience and devotion to advancing medicine.</p>
  
  <h2>Awards and honours</h2>
  <p>In recognition of her groundbreaking work, Karikó has received numerous honors, including the Breakthrough Prize in Life Sciences (2023), the Lasker-DeBakey Clinical Medical Research Award (2022), and induction into the National Inventors Hall of Fame (2023). She has also been awarded honorary degrees from several universities and recognized by scientific organizations worldwide for her contributions to medicine and biotechnology.</p>
  
  <h2>Legacy and impact</h2>
  <p>Karikó's research has catalyzed a revolution in vaccine development and gene therapy, impacting global health. Her perseverance illustrates how scientific breakthroughs often depend on dedication in the face of adversity. Her work has paved the way for personalized medicine, mRNA vaccines for other infectious diseases, and novel treatments for various conditions, positioning her as a key figure in biomedical innovation.</p>
  
  <h2>References</h2>
  <ol>
    <li>Gabriel, S. "How Katalin Karikó’s persistence paid off." <i>The New York Times</i>, 12 May 2023.</li>
    <li>Makwana, S. "The Scientist Behind the mRNA Revolution." <i>Scientific American</i>, 20 April 2023.</li>
    <li>"Katalin Karikó awarded the Lasker Award." <i>National Institutes of Health</i>, 12 September 2022.</li>
    <li>Johnson, M. "Pioneering female scientist’s journey from Hungary to global recognition." <i>BBC News</i>, 5 November 2023.</li>
  </ol>
  
  <footer class="categories">Categories: 1955 births; Living people; Hungarian scientists; American scientists; Biochemists; RNA researchers; COVID-19 vaccine developers; Biotech innovators</footer>
</body>
</html>